Capital Analysts LLC boosted its stake in The Cigna Group (NYSE:CI - Free Report) by 9.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,371 shares of the health services provider's stock after buying an additional 1,088 shares during the quarter. Capital Analysts LLC's holdings in The Cigna Group were worth $3,416,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. Lord Abbett & CO. LLC lifted its stake in The Cigna Group by 10.9% in the fourth quarter. Lord Abbett & CO. LLC now owns 7,117 shares of the health services provider's stock valued at $1,965,000 after acquiring an additional 700 shares during the last quarter. Kovitz Investment Group Partners LLC lifted its stake in shares of The Cigna Group by 6.5% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 46,052 shares of the health services provider's stock valued at $12,717,000 after purchasing an additional 2,820 shares during the last quarter. Van Den Berg Management I Inc. boosted its holdings in The Cigna Group by 185.5% in the fourth quarter. Van Den Berg Management I Inc. now owns 13,131 shares of the health services provider's stock worth $3,626,000 after purchasing an additional 8,532 shares in the last quarter. Voya Investment Management LLC increased its position in The Cigna Group by 28.1% during the fourth quarter. Voya Investment Management LLC now owns 346,992 shares of the health services provider's stock worth $95,818,000 after buying an additional 76,050 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. bought a new position in The Cigna Group during the fourth quarter valued at about $724,517,000. Institutional investors and hedge funds own 86.99% of the company's stock.
Insider Activity at The Cigna Group
In other The Cigna Group news, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the transaction, the insider now owns 29,421 shares of the company's stock, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock valued at $13,603,991 in the last ninety days. Insiders own 0.70% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently issued reports on CI. Piper Sandler reiterated an "overweight" rating and set a $348.00 price target (down previously from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. StockNews.com raised shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, April 8th. Truist Financial upped their price objective on shares of The Cigna Group from $375.00 to $385.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Guggenheim began coverage on The Cigna Group in a report on Wednesday, April 9th. They issued a "buy" rating and a $384.00 target price on the stock. Finally, Sanford C. Bernstein cut shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price for the company. in a research note on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, The Cigna Group has a consensus rating of "Buy" and an average price target of $373.56.
Get Our Latest Research Report on The Cigna Group
The Cigna Group Stock Down 0.0 %
Shares of CI opened at $335.60 on Friday. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The stock has a market cap of $91.85 billion, a price-to-earnings ratio of 27.42, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a 50-day moving average price of $319.82 and a two-hundred day moving average price of $310.44. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.
The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company posted $6.79 EPS. Equities analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.
The Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group's dividend payout ratio (DPR) is currently 49.35%.
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
